These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26229332)

  • 21. Clear Cell Carcinomas of Müllerian Type and Rete Testis Origin Presenting as Scrotal Masses: A Study of Seven Cases.
    Kilic I; Acosta AM; Ulbright TM
    Am J Surg Pathol; 2024 Jul; ():. PubMed ID: 38990735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C; McCluggage WG
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paratesticular papillary serous cystadenocarcinoma--a case report.
    Kurian RR; Prema NS; Belthazar A
    Indian J Pathol Microbiol; 2006 Jan; 49(1):36-7. PubMed ID: 16625973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotypic analysis of ovarian and testicular Müllerian papillary serous tumors.
    Carano KS; Soslow RA
    Mod Pathol; 1997 May; 10(5):414-20. PubMed ID: 9160304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrous pseudotumors of tunica albuginea, tunica vaginalis and epididymis: report of two cases.
    Ugras S; Yesil C
    Cancer Epidemiol; 2009 Jul; 33(1):69-71. PubMed ID: 19679051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
    Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
    J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary borderline mucinous neoplasm of the testis: A case report and literature review.
    Menon S; Ahmed S; Desai S
    Indian J Urol; 2012 Apr; 28(2):224-6. PubMed ID: 22919149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary neoplasia of the female peritoneum.
    Fox H
    Histopathology; 1993 Aug; 23(2):103-10. PubMed ID: 8406381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic serous carcinoma of the testis: a case report and review of the literature.
    Ma YT; Chaudhri S; Cullen MH
    Case Rep Oncol; 2011 Apr; 4(1):246-9. PubMed ID: 21589850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases.
    Bostwick DG; Tazelaar HD; Ballon SC; Hendrickson MR; Kempson RL
    Cancer; 1986 Nov; 58(9):2052-65. PubMed ID: 3756820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratesticular borderline serous tumor.
    Abdullah LS; Gupta R; Arnst A
    Int J Urol; 2006 Dec; 13(12):1536-8. PubMed ID: 17118032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
    Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
    Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging manifestations of ovarian mullerian mixed epithelial borderline tumors: imaging and histologic features in comparison with mullerian mucinous borderline tumors.
    Matsubayashi RN; Matsuo Y; Nakazono T; Momosaki S; Muranaka T
    J Comput Assist Tomogr; 2015; 39(2):276-80. PubMed ID: 25474142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.
    Choi YL; Kang SY; Shin YK; Choi JS; Kim SH; Lee SJ; Bae DS; Ahn G
    Virchows Arch; 2006 Mar; 448(3):331-6. PubMed ID: 16315018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rat model of serous borderline ovarian tumors induced by 7,12-dimethylbenz[a]anthracene.
    Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Li X; Qiang JW
    Exp Anim; 2019 Aug; 68(3):257-265. PubMed ID: 30760660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging findings of cellular angiofibroma of the tunica vaginalis of the testis: a case report.
    Ntorkou AA; Tsili AC; Giannakis D; Batistatou A; Stavrou S; Sofikitis N; Argyropoulou MI
    J Med Case Rep; 2016 Mar; 10():71. PubMed ID: 27029567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
    Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
    Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.